GROUP ONE TRADING, L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U958. A total of 4 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$906,000
+1385.2%
13,300
+600.0%
0.00%
Q2 2022$61,000
-84.3%
1,900
-83.0%
0.00%
Q1 2022$388,000
-67.7%
11,200
-72.7%
0.00%
-100.0%
Q4 2021$1,200,000
+20.5%
41,000
+4.9%
0.00%0.0%
Q3 2021$996,000
+40.1%
39,100
+92.6%
0.00%0.0%
Q2 2021$711,000
-80.1%
20,300
-76.8%
0.00%
-80.0%
Q1 2021$3,570,000
-66.0%
87,600
-63.8%
0.01%
-72.2%
Q4 2020$10,494,000
+128.5%
242,300
+190.9%
0.02%
+28.6%
Q3 2020$4,593,000
+13.0%
83,300
+29.3%
0.01%
-26.3%
Q2 2020$4,066,000
-35.7%
64,400
-47.9%
0.02%
-62.7%
Q1 2020$6,320,000
+37.5%
123,700
+114.0%
0.05%
+64.5%
Q4 2019$4,595,000
+185.2%
57,800
+74.1%
0.03%
+138.5%
Q3 2019$1,611,000
-68.6%
33,200
-66.0%
0.01%
-71.7%
Q2 2019$5,134,000
+1193.2%
97,600
+1201.3%
0.05%
+1050.0%
Q1 2019$397,000
-85.7%
7,500
-88.9%
0.00%
-83.3%
Q4 2018$2,771,000
-15.9%
67,500
-22.1%
0.02%
-7.7%
Q3 2018$3,295,000
-45.0%
86,700
-34.6%
0.03%
-49.0%
Q2 2018$5,994,000
+126.9%
132,600
+142.4%
0.05%
+88.9%
Q1 2018$2,642,000
-47.8%
54,700
-57.5%
0.03%
-25.0%
Q4 2017$5,064,000
+1225.7%
128,700
+946.3%
0.04%
+1100.0%
Q3 2017$382,000
-15.3%
12,300
-25.5%
0.00%
-40.0%
Q2 2017$451,000
-27.6%
16,500
-2.4%
0.01%
-28.6%
Q1 2017$623,000
+323.8%
16,900
+65.7%
0.01%
+600.0%
Q4 2016$147,000
+1737.5%
10,200
+1940.0%
0.00%
Q2 2016$8,0005000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 249,800$7,981,0000.00%
SIMPLEX TRADING, LLC 28,200$900,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,900$61,0000.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders